L, C., H, G., D, S., M, R., R, K., R, M., . . . RG, P. (2026). SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: Insights from a multi-ethnic population. Diabetologia, 69(8), 2189. https://doi.org/10.1007/s00125-026-06733-2
Chicago Style (17th ed.) CitationL, Chepulis, et al. "SGLT2 Inhibitor Use and Disparities in All-cause Mortality in Type 2 Diabetes: Insights from a Multi-ethnic Population." Diabetologia 69, no. 8 (2026): 2189. https://doi.org/10.1007/s00125-026-06733-2.
MLA (9th ed.) CitationL, Chepulis, et al. "SGLT2 Inhibitor Use and Disparities in All-cause Mortality in Type 2 Diabetes: Insights from a Multi-ethnic Population." Diabetologia, vol. 69, no. 8, 2026, p. 2189, https://doi.org/10.1007/s00125-026-06733-2.
Warning: These citations may not always be 100% accurate.
